ARTLVSNRSN• 3 Months (Normalized)
ARTL vs NRSN (Artelo Biosciences Inc. vs NeuroSense Therapeutics Ltd.)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
+%
Artelo Biosciences Inc.
Normalized Baseline0.00%
NRSN Performance $4.78
+575.14%
NeuroSense Therapeutics Ltd.
Normalized Baseline0.00%
Alpha Spread Margin NRSN LEADS
-575.14 pts
NRSN outperforming by 575.14 percentage points
ARTLNRSN
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL NRSN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(62 dates)
| Date | ARTL Price | ARTL Gain (%) | NRSN Price | NRSN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $- | $4.78 | +575.14% | - | |
| Sep 28, 2026 | $- | $5.10 | +620.34% | - | |
| Sep 25, 2026 | $4.54 | -54.55% | $6.95 | +881.64% | -936.19% |
| Sep 24, 2026 | $5.17 | -48.25% | $7.40 | +945.20% | -993.45% |
| Sep 23, 2026 | $7.31 | -26.83% | $7.40 | +945.20% | -972.03% |
| Sep 22, 2026 | $4.15 | -58.46% | $7.18 | +914.12% | -972.58% |
| Sep 21, 2026 | $4.10 | -58.96% | $6.62 | +835.03% | -893.99% |
| Sep 18, 2026 | $3.94 | -60.56% | $6.35 | +796.89% | -857.45% |
| Sep 17, 2026 | $3.97 | -60.26% | $6.72 | +849.15% | -909.41% |
| Sep 16, 2026 | $3.75 | -62.46% | $6.49 | +816.67% | -879.13% |
| Sep 15, 2026 | $5.34 | -46.55% | $7.03 | +892.94% | -939.49% |
| Sep 14, 2026 | $4.87 | -51.25% | $6.90 | +874.58% | -925.83% |
| Sep 11, 2026 | $5.43 | -45.65% | $0.35 | -50.99% | +5.34% |
| Sep 10, 2026 | $5.63 | -43.64% | $0.33 | -53.11% | +9.47% |
| Sep 09, 2026 | $5.98 | -40.14% | $0.40 | -43.36% | +3.22% |
Page 1 of 5